ELI LILLY & CO (1LLY.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1LLY - US5324571083 - Common Stock
944.5 EUR
+17.3 (+1.87%)
Taking everything into account, 1LLY scores 6 out of 10 in our fundamental rating. 1LLY was compared to 55 industry peers in the Pharmaceuticals industry. While 1LLY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1LLY is valued quite expensively, but it does show have an excellent growth rating. This makes 1LLY very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year 1LLY was profitable.
In the past year 1LLY had a positive cash flow from operations.
In the past 5 years 1LLY has always been profitable.
Each year in the past 5 years 1LLY had a positive operating cash flow.
1.2 Ratios
The Return On Assets of 1LLY (16.02%) is better than 90.91% of its industry peers.
Looking at the Return On Equity, with a value of 77.38%, 1LLY belongs to the top of the industry, outperforming 98.18% of the companies in the same industry.
The Return On Invested Capital of 1LLY (28.84%) is better than 96.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1LLY is significantly above the industry average of 14.90%.
The last Return On Invested Capital (28.84%) for 1LLY is above the 3 year average (21.71%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROIC | 28.84% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
1.3 Margins
With an excellent Profit Margin value of 30.99%, 1LLY belongs to the best of the industry, outperforming 98.18% of the companies in the same industry.
In the last couple of years the Profit Margin of 1LLY has declined.
1LLY's Operating Margin of 44.41% is amongst the best of the industry. 1LLY outperforms 98.18% of its industry peers.
1LLY's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 83.03%, 1LLY belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
1LLY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% |
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1LLY is creating value.
The number of shares outstanding for 1LLY remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1LLY has less shares outstanding
1LLY has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.44 indicates that 1LLY is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.44, 1LLY belongs to the top of the industry, outperforming 94.55% of the companies in the same industry.
1LLY has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as 1LLY would need 6.60 years to pay back of all of its debts.
With a Debt to FCF ratio value of 6.60, 1LLY is not doing good in the industry: 61.82% of the companies in the same industry are doing better.
1LLY has a Debt/Equity ratio of 1.72. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.72, 1LLY is not doing good in the industry: 74.55% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 8.44 |
ROIC/WACC3.29
WACC8.77%
2.3 Liquidity
A Current Ratio of 1.55 indicates that 1LLY should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.55, 1LLY is doing good in the industry, outperforming 63.64% of the companies in the same industry.
A Quick Ratio of 1.24 indicates that 1LLY should not have too much problems paying its short term obligations.
1LLY has a Quick ratio of 1.24. This is in the better half of the industry: 1LLY outperforms 70.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 116.22% over the past year.
1LLY shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.57% yearly.
The Revenue has grown by 45.41% in the past year. This is a very strong growth!
The Revenue has been growing by 15.08% on average over the past years. This is quite good.
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
3.2 Future
Based on estimates for the next years, 1LLY will show a very strong growth in Earnings Per Share. The EPS will grow by 30.75% on average per year.
1LLY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.43% yearly.
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 49.58 indicates a quite expensive valuation of 1LLY.
Based on the Price/Earnings ratio, 1LLY is valued a bit more expensive than 61.82% of the companies in the same industry.
When comparing the Price/Earnings ratio of 1LLY to the average of the S&P500 Index (25.98), we can say 1LLY is valued expensively.
Based on the Price/Forward Earnings ratio of 35.07, the valuation of 1LLY can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of 1LLY indicates a slightly more expensive valuation: 1LLY is more expensive than 63.64% of the companies listed in the same industry.
1LLY's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 35.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.58 | ||
| Fwd PE | 35.07 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1LLY is valued a bit more expensive than 69.09% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, 1LLY is valued a bit more expensive than 67.27% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 160.33 | ||
| EV/EBITDA | 36.96 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
1LLY has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1LLY's earnings are expected to grow with 42.29% in the coming years.
PEG (NY)0.61
PEG (5Y)2.99
EPS Next 2Y54.64%
EPS Next 3Y42.29%
5. Dividend
5.1 Amount
1LLY has a yearly dividend return of 0.58%, which is pretty low.
Compared to an average industry Dividend Yield of 3.00, 1LLY has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, 1LLY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
5.2 History
On average, the dividend of 1LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
1LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
The dividend of 1LLY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.28%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
BIT:1LLY (11/25/2025, 7:00:00 PM)
944.5
+17.3 (+1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners83.75%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap893.93B
Revenue(TTM)59.42B
Net Income(TTM)18.41B
Analysts80
Price Target881.23 (-6.7%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.58% |
Yearly Dividend4.28
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)14.71%
PT rev (3m)15.22%
EPS NQ rev (1m)1.97%
EPS NQ rev (3m)2.68%
EPS NY rev (1m)3.7%
EPS NY rev (3m)2.29%
Revenue NQ rev (1m)1.67%
Revenue NQ rev (3m)1.92%
Revenue NY rev (1m)1.44%
Revenue NY rev (3m)1.3%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 49.58 | ||
| Fwd PE | 35.07 | ||
| P/S | 17.37 | ||
| P/FCF | 160.33 | ||
| P/OCF | 64.25 | ||
| P/B | 43.37 | ||
| P/tB | 90.14 | ||
| EV/EBITDA | 36.96 |
EPS(TTM)19.05
EY2.02%
EPS(NY)26.93
Fwd EY2.85%
FCF(TTM)5.89
FCFY0.62%
OCF(TTM)14.7
OCFY1.56%
SpS54.38
BVpS21.78
TBVpS10.48
PEG (NY)0.61
PEG (5Y)2.99
Graham Number96.61
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.02% | ||
| ROE | 77.38% | ||
| ROCE | 35.28% | ||
| ROIC | 28.84% | ||
| ROICexc | 33.25% | ||
| ROICexgc | 41.06% | ||
| OM | 44.41% | ||
| PM (TTM) | 30.99% | ||
| GM | 83.03% | ||
| FCFM | 10.83% |
ROA(3y)11.42%
ROA(5y)11.8%
ROE(3y)60.64%
ROE(5y)70.77%
ROIC(3y)21.71%
ROIC(5y)19.96%
ROICexc(3y)23.23%
ROICexc(5y)21.74%
ROICexgc(3y)32.89%
ROICexgc(5y)32.31%
ROCE(3y)29.19%
ROCE(5y)26%
ROICexgc growth 3Y1.59%
ROICexgc growth 5Y4.02%
ROICexc growth 3Y9.55%
ROICexc growth 5Y8.82%
OM growth 3Y12.38%
OM growth 5Y7.84%
PM growth 3Y6.05%
PM growth 5Y-8.8%
GM growth 3Y3.11%
GM growth 5Y0.62%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.72 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 1.44 | ||
| Cap/Depr | 507.66% | ||
| Cap/Sales | 16.2% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 56.78% | ||
| Profit Quality | 34.96% | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 8.44 |
F-Score7
WACC8.77%
ROIC/WACC3.29
Cap/Depr(3y)385.26%
Cap/Depr(5y)286.02%
Cap/Sales(3y)16.93%
Cap/Sales(5y)13.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.22%
EPS 3Y16.75%
EPS 5Y16.57%
EPS Q2Q%494.92%
EPS Next Y80.9%
EPS Next 2Y54.64%
EPS Next 3Y42.29%
EPS Next 5Y30.75%
Revenue 1Y (TTM)45.41%
Revenue growth 3Y16.73%
Revenue growth 5Y15.08%
Sales Q2Q%53.87%
Revenue Next Year38.67%
Revenue Next 2Y28.28%
Revenue Next 3Y23.95%
Revenue Next 5Y18.43%
EBIT growth 1Y82.81%
EBIT growth 3Y31.18%
EBIT growth 5Y24.1%
EBIT Next Year93.86%
EBIT Next 3Y42.49%
EBIT Next 5Y30.03%
FCF growth 1Y4003.21%
FCF growth 3Y-57.48%
FCF growth 5Y-34.68%
OCF growth 1Y158.46%
OCF growth 3Y6.69%
OCF growth 5Y12.76%
ELI LILLY & CO / 1LLY.MI FAQ
What is the fundamental rating for 1LLY stock?
ChartMill assigns a fundamental rating of 6 / 10 to 1LLY.MI.
Can you provide the valuation status for ELI LILLY & CO?
ChartMill assigns a valuation rating of 3 / 10 to ELI LILLY & CO (1LLY.MI). This can be considered as Overvalued.
Can you provide the profitability details for ELI LILLY & CO?
ELI LILLY & CO (1LLY.MI) has a profitability rating of 9 / 10.
Can you provide the PE and PB ratios for 1LLY stock?
The Price/Earnings (PE) ratio for ELI LILLY & CO (1LLY.MI) is 49.58 and the Price/Book (PB) ratio is 43.37.
How financially healthy is ELI LILLY & CO?
The financial health rating of ELI LILLY & CO (1LLY.MI) is 5 / 10.